Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease

NCT02067832 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02067832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02067832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2013
Completion date
December 31, 2025
Enrollment
302 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

chronic graft vs host disease